Dosimetry is alive and well

Cancer Biotherapy and Radiopharmaceuticals

Volumn 25, Issue 5, 2010, Pages 593-595

  Lassmann, Michael ^a   Strigari, L ^b   Bardiès, Manuel ^c  

^a UNIVERSITY OF WÜRZBURG   (Germany)

^b Regina Helena Cancer Institute   (Italy)

^c UNIVERSITÉ DE NANTES   (France)

Author keywords

[No Author keywords available]

Indexed keywords

YTTRIUM 86;

BONE MARROW TOXICITY; DOSE CALCULATION; DOSE RESPONSE; DOSIMETRY; DRUG EFFICACY; EXTERNAL BEAM RADIOTHERAPY; HUMAN; LETTER; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; RADIATION DOSE FRACTIONATION; RADIONUCLIDE THERAPY; RADIOTHERAPY; THYROID CANCER;

DOSE-RESPONSE RELATIONSHIP, RADIATION; HUMANS; RADIOISOTOPES; RADIOMETRY; RADIOTHERAPY DOSAGE;

EID: 77958156370     PISSN: 10849785     EISSN: None     Source Type: Journal    
DOI: 10.1089/cbr.2010.0874     Document Type: Letter

References (22)

1. Sgouros G. Toward patient-friendly cell-level dosimetry. J Nucl Med 2007;48:496.
2. Stabin M, Brill AB. Physics applications in nuclear medicine: Carpe photon. J Nucl Med 2007;48:35N.
3. Flux G, Bardies M, Chiesa C, et al. Clinical radionuclide therapy dosimetry: The quest for the "Holy Gray." Eur J Nucl Med Mol Imaging 2007;34:1699.
4. Loevinger R, Budinger TF, Watson EE. MIRD Primer for Absorbed Dose Calculations, rev. ed. New York: The Society of Nuclear Medicine, 1991.
5. Divoli A, Chiavassa S, Ferrer L, et al. Effect of patient morphology on dosimetric calculations for internal irradiation as assessed by comparisons of Monte Carlo versus conventional methodologies. J Nucl Med 2009;50:316.
6. 90Y-Epratuzumab): Do tumor targeting and dosimetry predict therapeutic response? J Nucl Med 2003;44:2000.
7. Brans B, Bodei L, Giammarile F, et al. Clinical radionuclide therapy dosimetry: The quest for the "Holy Gray" [review]. Eur J Nucl Med Mol Imaging 2007;34:772.
8. Ferrer L, Kraeber-Bodere F, Bodet-Milin C, et al. Three methods assessing red marrow dosimetry in lymphoma patients treated with radioimmunotherapy. Cancer 2010;116(4 suppl): 1093.
9. Buckley SE, Chittenden SJ, Saran FH, et al. Whole-body dosimetry for individualized treatment planning of 131I-MIBG radionuclide therapy for neuroblastoma. J Nucl Med 2009;50:1518.
10. Flux GD, Haq M, Chittenden SJ, et al. A dose-effect correlation for radioiodine ablation in differentiated thyroid cancer. Eur J Nucl Med Mol Imaging 2010;37:270.
11. Prideaux AR, Song H, Hobbs RF, et al. Three-dimensional radiobiologic dosimetry: Application of radiobiologic modeling to patient-specific 3-dimensional imaging-based internal dosimetry. J Nucl Med 2007;48:1008.
12. Pauwels S, Barone R, Walrand S, et al. Practical dosimetry of peptide receptor radionuclide therapy with (90) Y-labeled somatostatin analogs. J Nucl Med 2005;46(suppl 1):92S.
13. Barone R, Borson-Chazot F, Valkema R, et al. Patient-specific dosimetry in predicting renal toxicity with (90) Y-DOTA-TOC: Relevance of kidney volume and dose rate in finding a dose-effect relationship. J Nucl Med 2005;46(suppl 1):99S.
14. Stabin MG. MIRDOSE: Personal computer software for internal dose assessment in nuclear medicine. J Nucl Med 1996;37:538;
15. comment in J Nucl Med 1998;39:927.
16. Bouchet LG, Bolch WE, Blanco HP, et al. MIRD Pamphlet No 19: Absorbed fractions and radionuclide S values for six age-dependent multiregion models of the kidney. J Nucl Med 2003;44:1113.
17. Konijnenberg M, Melis M, Valkema R, et al. Radiation dose distribution in human kidneys by octreotides in peptide receptor radionuclide therapy. J Nucl Med 2007;48:134.
18. Wessels BW, Konijnenberg MW, Dale RG, et al. MIRD pamphlet No. 20: The effect of model assumptions on kidney dosimetry and response-implications for radionuclide therapy. J Nucl Med 2008;49:1884.
19. Fowler JF. 21 years of biologically effective dose. Br J Radiol 2010;83:554.
20. Fowler JF. The linear-quadratic formula and progress in fractionated radiotherapy. Br J Radiol 1989;62:679.
21. Lassmann M, Brans B, Behr T. Introduction. 1st International Symposium on Radionuclide Therapy and Radiopharmaceutical Dosimetry. Cancer Biother Radiopharm 2005;20:45.
22. Lassmann M, Chiesa C, Flux GD, Bardies M. EANM Dosimetry Committee guidance document: Good practice of clinical dosimetry reporting. Eur J Nucl Med Mol Imaging 2010;37: in press.